Uncategorized


RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.

May 12th, 2021 - Ryan Allway

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM“) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“Canapar”) and a wholly-owned subsidiary of the […]

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

May 10th, 2021 - Ryan Allway

San Diego, California–(Newsfile Corp. – May 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO), to support Tryp’s clinical development of its Psilocybin-for-Neuropsychiatric Disorders (PFNTM) program.   Clinlogix […]

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

May 4th, 2021 - Ryan Allway

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its previously announced lab services agreement with Numinus Wellness Inc. (“Numinus”) (TSXV: NUMI) is progressing forward with […]

GrowGeneration Announces Belushi’s Farm Partnership

April 30th, 2021 - Ryan Allway

Belushi’s Farm Taps Nation’s Leading Hydroponics Retailer to Outfit New Greenhouse   DENVER, April 30, 2021 /PRNewswire/ – GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGen” or the “Company”) the nation’s largest chain of specialty hydroponic and organic garden centers, today announced a new partnership with Belushi’s Farm to outfit its newest greenhouse. Based in Oregon, Belushi’s Farm was founded in 2015 by performer […]

SOL Global Announces Investment in Cannabis Data and Compliance Solutions Company Fyllo

April 6th, 2021 - Ryan Allway

TORONTO-April 6, 2021, (BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company“) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has completed an investment in Fyllo, the leader in digital marketing and compliance solutions technology for highly regulated industries, as part of the close of Fyllo’s USD$30 million Series B […]

Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

April 6th, 2021 - Ryan Allway

HaluGen’s DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy   Vancouver, British Columbia–(Newsfile Corp. – April 6, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industry’s first Psychedelics […]

TransCanna Closes Unit Financing, Completes Daly Facility Loan, Issues Shares for Debt and Receives MCTO

April 1st, 2021 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – April 1, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has closed a Unit financing, completed the Daly Facility Construction Loan Agreement, issued shares for debt to certain employees and received an MCTO. “Thank you to all of our shareholders for […]

Red White & Bloom Provides Corporate Update

March 31st, 2021 - Ryan Allway

– Platinum branded products continue to see increased demand with a Platinum Michigan record for the short month of February  – High Times® product launch in Michigan accelerating with over 50 dispensaries to carry High Times branded product on full launch  – Company continues to make progress on closing of acquisitions in Michigan, Illinois and Florida […]

Subversive Acquisition LP Provides Update on Qualifying Transaction with Intercure, Israel’s Leading and Fastest-Growing Cannabis Company

March 29th, 2021 - Ryan Allway

Transaction Expected to Close on April 8, 2021 SVX to Hold Unitholders Meeting on April 6, 2021 InterCure Shares Expected to be Listed on TSX on Closing, and Subsequently also on NASDAQ SVX has met Cash Closing Condition Proxy Voting Deadline is April 1, 2021 Redemption Deadlines are March 31, 2021 and April 5, 2021 for the RVU’s and QT Redemption, respectively […]

Vireo Health Closes First Tranche of Debt Financing with Green Ivy Capital

March 26th, 2021 - Ryan Allway

— Credit facility provides growth capital to expand first-mover advantage in Vireo’s core markets — Company plans to begin incremental expansion projects at its Arizona and Maryland facilities in Q2 MINNEAPOLIS, March 26, 2021 /PRNewswire/ — Vireo Health International Inc., (“Vireo” or the “Company”) (CNSX: VREO,OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced that it […]

Bruce Linton-led Gage Cannabis files for direct listing in Canada – sources

March 24th, 2021 - Ryan Allway

(Corrects headline to say direct listing, not IPO) (Reuters) – U.S.-based Gage Cannabis Co, led by veteran marijuana industry executive Bruce Linton, is pursuing a direct listing on the Canadian Securities Exchange, sources familiar with the matter told Reuters. Gage is looking to tap into soaring investor demand for U.S. marijuana producers as the industry […]

Trulieve Reports Fourth Quarter and Full-Year 2020 Results and Announces Full-Year 2021 Guidance

March 23rd, 2021 - Ryan Allway

TALLAHASSEE, Fla., March 23, 2021 /CNW/ -Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced its results for the quarter and year ended December 31, 2020. The Company became a U.S. reporting company effective February 4, 2021. As such, the company’s financial statements are reported in […]

Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest

March 11th, 2021 - Ryan Allway

Accelerates Organigram’s R&D and product pipeline development, provides meaningful capital injection of ~C$221 million and strengthens Organigram’s ability to compete in existing markets and expand into U.S. and internationally March 11, 2021 06:00 AM Eastern Standard Time MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 […]

Silver Spike Acquisition Corp II Announces Pricing of $250 Million Initial Public Offering

March 10th, 2021 - Ryan Allway

March 10, 2021 08:52 PM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Silver Spike Acquisition Corp II (the “Company”) announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “SPKBU” beginning on […]

GTEC Announces $15 Million Bought Deal Offering of Units

March 10th, 2021 - Ryan Allway

KELOWNA, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) — GTEC Holdings Ltd. d/b/a GTEC Cannabis Co. (TSXV:GTEC) (OTCQB: GGTTF) (FRA: 1BUP) (“GTEC”, the “Company” or “GTEC Cannabis Co.”) a multi-licensed producer of handcrafted, high quality cannabis, is pleased to announce that it has entered into an agreement with Desjardins Capital Markets and Eight Capital (the […]

Ionic Brands Announces Closing of the Acquisition of Cowlitz County Cannabis From Lobe Sciences, Completing the Series of Transormational Corporate Transcations

March 8th, 2021 - Ryan Allway

TACOMA, WA / ACCESSWIRE / March 8, 2021 / IONIC BRANDS CORP. (CSE:IONC)(OTC PINK:IONKD)(FRA:IB3A) (“IONIC BRANDS” or the “Company“), a regional manufacturer of innovative cannabis consumables and concentrate extract products, is pleased to announce the closing of the acquisition of the cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe Sciences […]

Psychedelic Wellness-Focused Company, Delic Holdings, Announces Acquisition of Homestead

March 4th, 2021 - Ryan Allway

VANCOUVER, BC, March 4, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the acquisition of Homestead brand and intellectual property. Homestead is a legacy counterculture distributor of psychedelic media and creator of one of the first self-contained mushroom grow kits. Matt Stang, Founder and CEO […]

Ovation Science Increases Access to U.S. Investors with Listing on OTCQB Under the Symbol OVATF

February 24th, 2021 - Ryan Allway

VANCOUVER, BC and LAS VEGAS, Feb. 23, 2021 /PRNewswire/ – (CSE: OVAT) (OTC: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, is pleased to announce it has secured a U.S. listing on the OTCQB (“OTCQB […]

Kaya Reaches Beyond Oregon

February 17th, 2021 - Ryan Allway

  In early 2014, in a small office in Hollywood, Florida, the management of what is today Kaya Holdings made the strategic decision to transition their existing small-cap publicly traded biofuels company away from alternative energy and exclusively toward the cultivation and retail of legal cannabis. This was no ordinary decision; Colorado and Washington had […]

Calling All Derivatives; The Psychedelic Space Needs You

February 15th, 2021 - Ash Stringer

In 2020, the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research approved 53 novel drug products, the second most clearances in a single year in 23 years, trailing only a record 59 in 2018. Amongst the new drugs, 58 percent were approved for rare diseases, maladies where patients have little hope due […]

Chemistree Investee – ImmunoFlex Receives NRC IRAP Funding

February 8th, 2021 - Ryan Allway

VANCOUVER, BC, Feb. 8, 2021 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). “ImmunoFlex is now recruiting […]

RAMM Pharma Makes Additional Investment in Canapar & Provides Overview of Strategic Acquisition to Enter European Cannabis Market

January 5th, 2021 - Ryan Allway

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce a C$3 million investment in Canapar Corp. (including its wholly owned subsidiaries, “Canapar”) through its participation in Canapar’s secured convertible […]

Australis Appoints Financial Leadership Veteran Jon Paul as CFO, Provides Corporate Update

December 31st, 2020 - Ryan Allway

Brings Strong track Record in Cannabis, Consumer and Pharma Industries New Leadership Team Continues to Execute LAS VEGAS, Dec. 30, 2020 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announces the Company has appointed Jon Paul as its new CFO, effective January 1, 2021. In addition, the Company provides a corporate update on the progress […]

Better Plant Subsidiary NeonMind Announces Filing of Final Prospectus in Connection with an Initial Public Offering

December 11th, 2020 - Ryan Allway

Vancouver, B.C. – December 10, 2020: Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) announces that on December 9, 2020 its majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind“) obtained a receipt for a final prospectus for an initial public offering (the “NeonMind IPO”) for the sale of up to […]

Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease

December 2nd, 2020 - Ryan Allway

Collaboration with the University of Maastricht of the Netherlands TEANECK, N.J.–(BUSINESS WIRE)–Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has entered into an investigator-sponsored study agreement with Maastricht University of the Netherlands. The research project is a clinical study to […]

CANNTAB ANNOUNCES CLOSING OF PURCHASES OF CANNABIS PROCESSING EQUIPMENT AND LEASEHOLD IMPROVEMENTS

October 20th, 2020 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – October 19, 2020) – Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the previously announced asset purchase agreement with CMAX Technologies Inc. (“CMAX“), a related party […]

MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products

October 20th, 2020 - Ryan Allway

BARRIE, Ontario, Oct. 20, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the launch of its new “LABS Cannabis” family of health and wellness products. Specially designed and formulated for the […]

Lotus Sees Strong Demand and an Undersupply of High-Quality Product in the Market

October 19th, 2020 - Ryan Allway

Vancouver Canada, October 19, 2020 – Lotus Ventures Inc. (“Lotus” or the “Company”) (CSE: J) (FRA: LV9) (OTC: LTTSF) comments in response to BNN Bloomberg’s article published on Friday, October 16, 2020 in regard to ‘Too much (cannabis) cultivation’ being narrated across Canada. From a macro industry analysis, this is a reasonable premise but in the Company’s experience some […]

Medcolcanna Organics Inc. Announces Listing on The NEO Exchange And Delisting of Common Shares From The TSXV

October 14th, 2020 - Ryan Allway

BOGOTÁ, Colombia, Oct. 13, 2020 (GLOBE NEWSWIRE) — Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that, further to its press release dated September 25, 2020, the Company will be listing its common shares (“Common Shares”) on NEO Exchange Inc. (the […]

Next Green Wave Surpasses 6 Months of Positive Cash Flow and Profitability

October 7th, 2020 - Ryan Allway

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”). As a follow up to our last press release on September 1, 2020, the Company is pleased to confirm the following financial milestones: – In the months of July, August and September 2020, the Company operated with positive cash flow, and […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading